Issue 3/2015
Content (8 Articles)
Current Opinion
Does Ketamine Have Anti-Suicidal Properties? Current Status and Future Directions
Rebecca B. Price, Sanjay J. Mathew
Therapy in Practice
Epidemiology and Management of Neuropsychiatric Disorders in Behçet’s Syndrome
Rosaria Talarico, Laura Palagini, Anna d’Ascanio, Elena Elefante, Claudia Ferrari, Chiara Stagnaro, Chiara Tani, Angelo Gemignani, Mauro Mauri, Stefano Bombardieri, Marta Mosca
Review Article
Antineuronal Antibodies Against Neurotransmitter Receptors and Synaptic Proteins in Schizophrenia: Current Knowledge and Clinical Implications
Johann Steiner, Kolja Schiltz, Hans-Gert Bernstein, Bernhard Bogerts
Review Article
Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
Maria Pia Amato, Emilio Portaccio
Review Article
Pharmacotherapy of Acute Mania: Monotherapy or Combination Therapy with Mood Stabilizers and Antipsychotics?
Iria Grande, Eduard Vieta
Review Article
Infection Risk in Patients on Multiple Sclerosis Therapeutics
Eric M. Williamson, Joseph R. Berger
Original Research Article
Serotonin–Norepinephrine Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor Use and Risk of Fractures: A New-User Cohort Study Among US Adults Aged 50 Years and Older
Amy Lanteigne, Yi-han Sheu, Til Stürmer, Virginia Pate, Deb Azrael, Sonja A. Swanson, Matthew Miller
Adis Drug Evaluation
Lurasidone: A Review of Its Use in Adult Patients with Bipolar I Depression
Mark Sanford, Sohita Dhillon